Mission and Vision

It is our vision to radically improve the assessment of Alzheimer’s disease (AD) and the care for Alzheimer’s patients. We aim to do so by exploring how mobile technologies – such as smart phones, wearables and home-based sensors – can be used to measure disability progression associated with AD.

These technologies allow us to sensitively measure cognitive and functional decline in people with Alzheimer’s Disease. However, it is currently unclear how we can use this potential to improve AD assessment and care – which is exactly what we are trying find out.

In this project, we aim to investigate how mobile technologies can improve our understanding of Alzheimer’s Disease. For example, these techniques might help to detect AD earlier in people with cognitive decline. Mobile technology also allows for a more personalized approach to AD treatment and care, so that people with this disease can live independently for longer. In addition, we also aim to identify “digital biomarkers” (electronic signals that give information about a person’s health status) for AD. This creates new perspectives for the development of treatments against this progressive and debilitating condition. 

We are only just starting to understand the possibilities of mobile technology in health care. In RADAR-AD we work closely together with patients, caregivers and regulators to ensure that adequate regulatory frameworks are developed, that technologies are safe, and that users are comfortable using these technologies. RADAR-AD will also draw on the wealth of lessons and expertise from the RADAR-CNS project. Together these projects form a concerted effort in developing innovative ways to use remote measuring technology for the benefit of patients.